Policy Changes And Partnerships Will Expand Ambulatory Market Reach

Shared on01 May 25
Fair value Decreased 14%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 3.93%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 0.43%

AnalystConsensusTarget has increased revenue growth from 6.5% to 10.1%, increased profit margin from 9.8% to 15.3% and increased future PE multiple from 7.5x to 11.6x.